Project Grant R01DA060228
Award Date 9/1/25
Completion Date 5/31/30
Dollars Obligated $795K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
- This Project Grant award for $440,000, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the therapeutic potential of the G protein-coupled receptor GPR6 as a novel target for treating cocaine use disorder. The key objectives include: 1) examining GPR6 expression in specific neuron subpopulations involved in cocaine reward processing, 2) evaluating GPR6 status following intravenous self-administration...
- This Project Grant award of $405,230 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to advance NR4A1 as a novel target for treating cocaine use disorder. The key objectives are to: 1) Synthesize and screen derivatives of the NR4A1 agonist Cytosporone B to identify lead compounds, and 2) Establish milestones towards filing a commercially-viable Investigational New Drug (IND) application for an NR4A1-targeted...
- This federal Project Grant award of $758,218 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the potential of nociceptin/orphanin FQ peptide (NOP) receptors as targets for novel pharmacotherapies to treat cocaine use disorder (CUD) in non-human primate models. The key products and services to be delivered under this award include: Examining how NOP receptors influence vulnerability to developing CUD...
- This $436,050 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate cell type and circuit-specific epigenetic mechanisms underlying cocaine addiction. The research will utilize a mouse model of repeated cocaine exposure to study how cocaine-induced molecular changes in specific brain regions and neuronal circuits lead to the development of addictive behaviors. The goal is to...
- This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $702,965 to the University of Texas Health Science Center at Houston to conduct a pilot mechanistic study on repurposing the drug semaglutide for the treatment of cocaine use disorder. The study aims to provide proof-of-concept evidence that semaglutide, a glucagon-like peptide receptor agonist, can modulate key reward-related mechanisms underlying cocaine use,...
- This Project Grant award of $139,998 from the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279) supports research to elucidate the cellular and neurochemical mechanisms underlying cocaine-induced suppression of inhibitory G protein-coupled receptor signaling in the prelimbic cortex of the brain. The research aims to investigate how cocaine exposure weakens the regulation of G protein-gated inwardly rectifying potassium (GIRK)...
- This $149,284 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to Vanderbilt University will fund research to understand how chronic cocaine use disrupts the neural processing of aversive, non-drug stimuli in the brain. The study aims to define the precise temporal parameters under which dopamine release modulates the activity of genetically-defined neuron populations in the nucleus accumbens, both at baseline and in...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) totaling $1,447,919.00 supports research on the "Cocaine Addition and the Need-State Hypothesis." The research project aims to test the hypothesis that addiction involves the hijacking of physiological need substrates, in addition to reward substrates. Specifically, the project will evaluate whether treatment with a Glucagon-Like Peptide-1...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $790,937 Cooperative Agreement under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Research Foundation for the State University of New York (RF SUNY), doing business as Sponsored Projects Services. This award supports research to understand the genetic factors that contribute to the transition from recreational to problematic drug use, with the goal of uncovering biological...
- This federal Project Grant award of $121,323.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will support research by the University of North Carolina at Chapel Hill to investigate the structural and functional responses of nucleus accumbens microglia following long-access cocaine self-administration. The research aims to elucidate the role of microglia and...